This work, published by Anisimov et al
While the RNI for maintenance is only 1.5 g daily, therapeutic oral doses typically range from: 50-150 g daily for mild deficiency prevention in at-risk groups 1,000-2,000 g daily for treating confirmed deficiency without malabsorption Some formulations contain up to 5,000 g, though there is no proven additional benefit over 1,000-2,000 g for most patients The reason for this dosage discrepancy lies in absorption efficiency
Bartesaghi S, Radi R (2018) Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration
NAD, while not a peptide, is frequently administered in the same longevity settings and reflects the broader ecosystem of perioperative supplementation (Gallagher and Emmanuel 2026)
The choice of bacteriostatic water directly impacts how long your reconstituted tirzepatide remains safe to use